# US 2006/0040878 A1 · Bacterial antigen induced bone morphogenesis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0040878 A1
- Document ID: US20060040878A1
- Status: Published application
- Kind: A1
- Application number: 10/922,174
- Filed: 2004-08-20
- Published: 2006-02-23
- Earliest claimed: 2004-08-20
- Inventors: Loubert Suddaby
- Web page: https://patentgrep.com/patent/US20060040878A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61K 39/02: Bacterial antigens
- A61L 27/365: {Bones}
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Bone growth following a spinal fusion procedure is enhanced by packing the fusion site with a mixture of a bone material such as allograft or autograft, and an antigen produced from bacteria or parasitic organisms. A composition for inducing bone morphogenesis also is disclosed.

## Claims

### Claim 1

Method of inducing bone morphogenesis comprising introducing into a surgical site a composition of bone material or matrix and an antigen.

### Claim 2 (depends on 1)

Method of claim 1, wherein the surgical site is between bones selected to be surgically fused in an animal or human being.

### Claim 3 (depends on 1)

Method of claim 1, wherein the surgical site is between vertebrae of a spinal column.

### Claim 4 (depends on 1)

Method of claim 1, wherein the bone material is selected from the group consisting of allograft material, autograft material, xenograft material, a calcium collagen admixture and combinations thereof.

### Claim 5 (depends on 1)

Method of claim 1, wherein the bone material is demineralized.

### Claim 6 (depends on 1)

Method of claim 1, wherein the bone matrix comprises particles larger than a microphage or 75 microns.

### Claim 7 (depends on 1)

Method of claim 1, wherein the bone matrix comprises ceramic powder or beads, glass powder or beads, metal powder or beads, calcium hydroxyapatite, calcium silicate, tricalcium phosphate or combinations thereof.

### Claim 8 (depends on 1)

Method of claim 1, wherein the antigen is selected from the group consisting of organisms known to infect the spine either pathologically or post-surgically, organisms known to have a propensity to induce ectopic calcification, and combinations thereof.

### Claim 9 (depends on 1)

Method of claim 1, wherein the antigen is selected from the group consisting of weakened bacteria, dead bacteria, weakened parasitic organisms, dead parasitic organisms and combinations thereof.

### Claim 10 (depends on 9)

Method of claim 9, wherein the composition comprises 0.01% to 0.5% of the antigen by weight.

### Claim 11 (depends on 1)

Method of claim 1, wherein the antigen is selected from the group consisting of Staphylococcus, Streptococcus, Cornybacterium, Listeria, Erysipelothrix, Bacillus, Clostridium, Neisseria, Sperillium, Pasturella, Brucella, Yersinia, Francisella, Hemophylus, Bordetella, Legionella, Escherichia, Salmonella, Shigella, Klebsiella, Proteus, Vibrio, Pseudomonas, Bacteroides, Fusobacterium, Mycoplasma, Escherichia Coli, mycobacterium and combinations thereof.

### Claim 12 (depends on 1)

Method of claim 1, wherein the antigen comprises a crude bacterial lysate, a teichoic acid, a teichuronic acid, a fractionated component of a bacterial or parasitic cell wall, cytoplasm, membrane, DNA or RNA, a lipoprotein, a lipopolysaccharide, a polysaccharide, a glycocalyx or combinations thereof.

### Claim 13 (depends on 12)

Method of claim 12, wherein a proportion of antigen-to-bone material or matrix ranges from one nanogram to one milligram of antigen for each milligram of bone matrix.

### Claim 14 (depends on 1)

Method of claim 1, further comprising introducing into the surgical site a chemoattractant for triggering bone morphogenesis.

### Claim 15 (depends on 14)

Method of claim 14, wherein the chemoattractant is selected from the group consisting of interleukin I, interleukin II, lymphokine, C reactive protein, endogenous pyrogen, prostaglandin and combinations thereof.

### Claim 16 (depends on 15)

Method of claim 15, wherein a proportion of chemoattractant-to-bone material or matrix ranges from one nanogram to one milligram of chemoattractant for each milligram of bone matrix.

### Claim 17

Composition for inducing bone morphogenesis comprising an effective amount of:
bone material or matrix; and
an antigen.

### Claim 18 (depends on 17)

Composition of claim 17, wherein said bone material is selected from the group consisting of allograft material, autograft material, xenograft material, a calcium collagen admixture and combinations thereof.

### Claim 19 (depends on 17)

Composition of claim 17, wherein said bone material is demineralized.

### Claim 20 (depends on 17)

Composition of claim 17, wherein said bone matrix comprises particles larger than a microphage or 75 microns.

### Claim 21 (depends on 17)

Composition of claim 17, wherein said bone matrix comprises ceramic powder or beads, glass powder or beads, metal powder or beads, calcium hydroxyapatite, calcium silicate, tricalcium phosphate or combinations thereof.

### Claim 22 (depends on 17)

Composition of claim 17, wherein said antigen is selected from the group consisting of organisms known to infect the spine either pathologically or post-surgically, organisms known to have a propensity to induce ectopic calcification, and combinations thereof.

### Claim 23 (depends on 17)

Composition of claim 17, wherein said antigen is selected from the group consisting of weakened bacteria, dead bacteria, weakened parasitic organisms, dead parasitic organisms and combinations thereof.

### Claim 24 (depends on 23)

Composition of claim 23, wherein said composition comprises 0.01% to 0.5% of said antigen by weight.

### Claim 25 (depends on 17)

Composition of claim 17, wherein said antigen is selected from the group consisting of Staphylococcus, Streptococcus, Cornybacterium, Listeria, Erysipelothrix, Bacillus, Clostridium, Neisseria, Sperillium, Pasturella, Brucella, Yersinia, Francisella, Hemophylus, Bordetella, Legionella, Escherichia, Salmonella, Shigella, Klebsiella, Proteus, Vibrio, Pseudomonas, Bacteroides, Fusobacterium, Mycoplasma, Escherichia Coli, mycobacterium and combinations thereof.

### Claim 26 (depends on 17)

Composition of claim 17, wherein said antigen comprises a crude bacterial lysate, a teichoic acid, a teichuronic acid, a fractionated component of a bacterial or parasitic cell wall, membrane, cytoplasm, DNA or RNA, a lipoprotein, a lipopolysaccharide, a polysaccharide, a glycocalyx or combinations thereof.

### Claim 27 (depends on 26)

Composition of claim 26, wherein a proportion of antigen-to-bone material or matrix ranges from one nanogram to one milligram of antigen for each milligram of bone matrix.

### Claim 28 (depends on 17)

Composition of claim 17, further comprising introducing into the surgical site a chemoattractant for triggering bone morphogenesis.

### Claim 29 (depends on 28)

Composition of claim 28, wherein said chemoattractant is selected from the group consisting of interleukin I, interleukin II, lymphokine, C reactive protein, endogenous pyrogen, prostaglandin and combinations thereof.

### Claim 30 (depends on 29)

Composition of claim 29, wherein a proportion of chemoattractant-to-bone material or matrix ranges from one nanogram to one milligram of chemoattractant for each milligram of bone matrix.
